Avitide, Llc, A Repligen Company

Avitide, Llc, A Repligen Company company information, Employees & Contact Information

Avitide, a Repligen Company, discovers, develops, manufactures and supplies custom and catalog biopharmaceutical affinity purification solutions to the biopharmaceutical industry. Avitide’s proprietary AVIPure™ affinity ligand portfolio sets the standard for precise affinity separations and consistent robust performance for its high-valued chromatographic products. Avitide develops these technologies with an industry-leading 3-month, concept to resin delivery service timeline that enables industry biopharmaceutical manufacturers and contract developers to achieve faster bioprocess development timelines, improved process economics, predictable scalability, and enable next-generation integrated continuous downstream processing. Avitide’s commercial resin manufacturing and supply operates under an ISO 9001:2015 quality management system and has been successfully audited for its quality systems and continuity of supply plan for its affinity chromatography products. Avitide has successfully deployed affinity purification technologies towards an array of biological molecules including enzymes, bispecific antibodies, therapeutic scaffolds, growth factors, hormones, insulins, blood factors, Fcfusions, cell-based therapies, vaccines, and gene therapy viral vectors. For more information, visit www.avitide.com.

Company Details

Employees
29
Founded
-
Address
16 Cavendish Court, Lebanon,new Hampshire 03766,united States
Phone
5159995181
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Lebanon, New Hampshire
Looking for a particular Avitide, Llc, A Repligen Company employee's phone or email?

Avitide, Llc, A Repligen Company Questions

News

Avitide to be Acquired for $150M - Business NH Magazine

Avitide to be Acquired for $150M Business NH Magazine

Repligen Announces Agreement to Acquire Avitide Inc. - GlobeNewswire

Repligen Announces Agreement to Acquire Avitide Inc. GlobeNewswire

Protein boost for Repligen through $150m Avitide buy - BioProcess International

Protein boost for Repligen through $150m Avitide buy BioProcess International

Repligen sees $150M Avitide acquisition as key to reaching gene therapy goals - MedCity News

Repligen sees $150M Avitide acquisition as key to reaching gene therapy goals MedCity News

Avitide Eyes 2019 Profitability with Series E Financing - Genetic Engineering and Biotechnology News

Avitide Eyes 2019 Profitability with Series E Financing Genetic Engineering and Biotechnology News

Tillman Gerngross project out of Dartmouth College acquired by Repligen - Endpoints News

Tillman Gerngross project out of Dartmouth College acquired by Repligen Endpoints News

Repligen shells out $150M for New Hampshire biotech Avitide - The Business Journals

Repligen shells out $150M for New Hampshire biotech Avitide The Business Journals

The Upper Valley has become a booming hub for biotech firms - Valley News

The Upper Valley has become a booming hub for biotech firms Valley News

Downstream Processing of Complex Molecules, Pure and Simple - Genetic Engineering and Biotechnology News

Downstream Processing of Complex Molecules, Pure and Simple Genetic Engineering and Biotechnology News

Repligen Announces Agreement to Acquire Chromatography Innovator Tantti - GlobeNewswire

Repligen Announces Agreement to Acquire Chromatography Innovator Tantti GlobeNewswire

Top Avitide, Llc, A Repligen Company Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant